Skip to main content
Fig. 2 | Molecular Cancer

Fig. 2

From: Differential expression analysis at the individual level reveals a lncRNA prognostic signature for lung adenocarcinoma

Fig. 2

A 2-lncRNA signature for LUAD patient prognosis. Kaplan-Meier estimates the overall survival using the 2-lncRNA signature in the a training dataset, b GSE50081 and c GSE31210. All the P values of Kaplan-Meier analysis were calculated using log-rank test. d The lncRNA C1orf132 was down-regulated in the high-risk patients. e The lncRNA TMPO-AS1 was up-regulated in the high-risk patients

Back to article page